IOL Chemicals and Pharmaceuticals Limited (BOM: 524164)

Market Cap	21.81B
Revenue (ttm)	20.52B
Net Income (ttm)	998.20M
Shares Out	58.71M
EPS (ttm)	17.01
PE Ratio	21.84
Forward PE	10.69
Dividend	5.00 (1.35%)
Ex-Dividend Date	n/a

Volume	20,242
Open	379.95
Previous Close	370.30
Day's Range	369.30 - 379.95
52-Week Range	333.00 - 537.05
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 12, 2024

About IOL Chemicals and Pharmaceuticals

IOL Chemicals and Pharmaceuticals Limited manufactures and sells pharmaceutical and chemical products in India and internationally. The company offers active pharmaceutical ingredients (API), such as ibuprofen lysinate and ibuprofen sodium; and other APIs, including metformin, fenofibrate, lamotrigine, clopidogrel bisulphate, pantoprazole, gabapentin, levetiracetam, paracetamol, etc. Its active pharmaceutical ingredients are used for the treatment of anti-inflammatory, analgesic and antipyretic, anti-diabetic, anti- platelet, anti-cholesterol, ...

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 1986
• Employees: 2,777
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 524164

Financial Performance

In 2023, IOL Chemicals and Pharmaceuticals's revenue was 21.33 billion, a decrease of -3.80% compared to the previous year's 22.17 billion. Earnings were 1.34 billion, a decrease of -3.39%.